Delivery Order SPE2DR25D2010-SPE2DR26F4ZFD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Pioglitazone HCL 30 mg tablets in quantities of 500 units, with a ceiling value of $1,031.24. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Pioglitazone HCL 30 mg tablets (500 count) with a ceiling value of $5,361.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is scheduled for completion by November 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $3,170.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pioglitazone HCL 30 mg tablets in a quantity of 500 units. This is a firm fixed-price delivery order valued at $1,502.62, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units) valued at $2,474.49. This non-competitive delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a firm fixed-price transaction under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pioglitazone HCL 15 mg tablets in a quantity of 90 count, valued at $1,904.05. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of October 22, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pioglitazone HCL 45 mg tablets in quantities of 500 units, with a ceiling value of $1,010.78. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $6,417.35. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pioglitazone is a diabetes management medication commonly...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.41 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (90-count units) with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The place of performance is...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZFDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 500 units, with a ceiling value of $1,553.29 and an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this prime contract vehicle to supply a wide spectrum of pharmaceuticals and medical supplies to support military healthcare programs, including medications for chronic disease management such as diabetes treatments. The company's extensive federal contracting history demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||